BIOLASE, Inc.
BIOLQ
$0.0078
$0.00034.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.28% | 33.72% | 28.41% | 27.95% | -4.64% |
| Total Depreciation and Amortization | 15.88% | 39.06% | 525.52% | 462.98% | 363.32% |
| Total Amortization of Deferred Charges | -26.67% | 0.27% | 39.24% | -27.01% | 496.62% |
| Total Other Non-Cash Items | -123.22% | -87.70% | -70.26% | -64.86% | -19.64% |
| Change in Net Operating Assets | -167.90% | 708.45% | 110.36% | 120.22% | 121.74% |
| Cash from Operations | 22.79% | 45.93% | 41.10% | 47.35% | 28.39% |
| Capital Expenditure | 84.22% | 90.37% | 81.95% | 64.82% | 55.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 118.03% | 101.76% | 91.40% | 69.71% | 55.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 67.00% | 83.50% | 100.00% |
| Issuance of Common Stock | -55.39% | -55.39% | -72.56% | 65.28% | 22.30% |
| Repurchase of Common Stock | 68.75% | -- | -- | -- | 85.05% |
| Issuance of Preferred Stock | -95.64% | -1.75% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.26% | 318.85% | -- | -- | 254.38% |
| Cash from Financing | -47.97% | -21.42% | 11.01% | 278.75% | 251.20% |
| Foreign Exchange rate Adjustments | -43.57% | -117.09% | 18.18% | 256.88% | 166.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.93% | 86.86% | 99.09% | 109.18% | 90.90% |
